angiotensin ii, des-phe(8)- has been researched along with 6-ketoprostaglandin f1 alpha in 3 studies
Studies (angiotensin ii, des-phe(8)-) | Trials (angiotensin ii, des-phe(8)-) | Recent Studies (post-2010) (angiotensin ii, des-phe(8)-) | Studies (6-ketoprostaglandin f1 alpha) | Trials (6-ketoprostaglandin f1 alpha) | Recent Studies (post-2010) (6-ketoprostaglandin f1 alpha) |
---|---|---|---|---|---|
1,533 | 21 | 995 | 4,832 | 294 | 150 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bell-Quilley, CP; Hilchey, SD | 1 |
Bayorh, MA; Eatman, D; Emmett, N; Socci, RR; Thierry-Palmer, M; Walton, M | 1 |
Del Valle-Mondragón, L; Guzmán-Hernández, EA; Ibarra-Barajas, M; Pastelín-Hernández, G; Sánchez-Mendoza, MA; Villalobos-Molina, R | 1 |
3 other study(ies) available for angiotensin ii, des-phe(8)- and 6-ketoprostaglandin f1 alpha
Article | Year |
---|---|
Association between the natriuretic action of angiotensin-(1-7) and selective stimulation of renal prostaglandin I2 release.
Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin I; Angiotensin II; Animals; Body Water; Electrolytes; Epoprostenol; Glomerular Filtration Rate; Indomethacin; Kidney; Male; Natriuresis; Peptide Fragments; Rats; Rats, Sprague-Dawley; Renal Circulation; Vascular Resistance | 1995 |
1A-779 attenuates angiotensin-(1-7) depressor response in salt-induced hypertensive rats.
Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin I; Angiotensin II; Animals; Blood Pressure; Body Weight; Cyclic GMP; Dinoprostone; Epoprostenol; Hypertension; Male; Nitric Oxide; Peptide Fragments; Platelet Aggregation Inhibitors; Rats; Rats, Inbred Dahl; Rats, Inbred SHR; Salts; Thromboxane A2; Thromboxane B2; Time Factors | 2002 |
Early co-expression of cyclooxygenase-2 and renin in the rat kidney cortex contributes to the development of N(G)-nitro-L-arginine methyl ester induced hypertension.
Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin I; Angiotensin II; Animals; Antihypertensive Agents; Captopril; Celecoxib; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Gene Expression Regulation; Hypertension, Renal; Kidney Cortex; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Peptide Fragments; Random Allocation; Rats, Wistar; Renin; RNA, Messenger | 2015 |